NCT05044676View on ClinicalTrials.gov

Immune Cells as a New Biomarker of Response in Patients Treated by Immunotherapy for Advanced Hepatocellular Carcinoma

RecruitingOBSERVATIONAL
Enrollment

120

Participants

Timeline

Start Date

September 8, 2023

Primary Completion Date

September 8, 2025

Study Completion Date

September 8, 2027

Conditions
Hepatocellular Carcinoma
Interventions
OTHER

patients with hepatocellular carcinoma

The response of the hepatocellular carcinoma to treatment will be evaluated as part of the care

Trial Locations (1)

75013

RECRUITING

Service hépato-gastroentérologie, Hôpital la Pitié-Salpêtrière, Paris

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER